Financhill
Back

Kodiak Sciences Quote, Financials, Valuation and Earnings

Kodiak Sciences Price Quote

$5.99
+0.20 (+3.45%)
(Updated: November 21, 2024 at 3:30 PM ET)

Kodiak Sciences Key Stats

Buy
62
Kodiak Sciences (KOD) is a Buy

Day range:
$5.60 - $5.92
52-week range:
$2.19 - $7.77
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.61%

Volume:
355.8K
Avg. volume:
379.4K
1-year change:
138.27%
Market cap:
$297.9M
Revenue:
$0
EPS:
$-3.65

How Much Does Kodiak Sciences Make?

Data Unavailable

Is Kodiak Sciences Growing As A Company?

Data Unavailable

Kodiak Sciences Stock Price Performance

  • Did Kodiak Sciences Stock Go Up Last Month?
    Kodiak Sciences share price went up by 59.94% last month
  • Did KOD's Share Price Rise Over The Last Year?
    KOD share price rose by 138.27% over the past 1 year

What Is Kodiak Sciences 52-Week High & Low?

Kodiak Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Kodiak Sciences?

  • How Much Debt Does Kodiak Sciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Kodiak Sciences Have?
    Cash and short term investments quarterly total is $197.9M
  • What Is Kodiak Sciences’s Book Value Per Share?
    Book value per share is 3.52

Is Kodiak Sciences Cash Flow Positive?

  • What Is KOD Cash Flow From Operations?
    Cash flow from operations (TTM) is -$119.5M
  • What Is Kodiak Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$27K
  • What Is Kodiak Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$28.4M

Kodiak Sciences Return On Invested Capital

Data Unavailable

Kodiak Sciences Earnings Date & Stock Price

Kodiak Sciences Competitors

  • Who Are Kodiak Sciences's Competitors?
    Below is a list of companies who compete with Kodiak Sciences or are related in some way:
    • Acumen Pharmaceuticals Inc (ABOS)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Pfizer Inc (PFE)
    • Palatin Technologies Inc (PTN)
    • Regeneron Pharmaceuticals Inc (REGN)

Kodiak Sciences Dividend Yield

Kodiak Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.62%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 4.00
Downside from Last Price: -30.92%

Major Shareholders

  • How many KOD shares are owned by institutional investors?
    46.3M KOD shares are owned by institutional investors
  • How many KOD shares are owned by insiders?
    3.9M KOD shares are owned by insiders